The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Codon-specific KRAS mutations predict overall survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.
 
Joris van de Haar
No Relationships to Disclose
 
Xuhui Ma
No Relationships to Disclose
 
Salo N. Ooft
No Relationships to Disclose
 
Pim W. van der Helm
No Relationships to Disclose
 
Louisa Rose Hoes
No Relationships to Disclose
 
Sara Mainardi
No Relationships to Disclose
 
Lodewyk F.A. Wessels
Research Funding - Genmab
 
Emile E. Voest
Consulting or Advisory Role - Aglaia BioMedical Ventures (Inst); Biogeneration Ventures; InteRNA; Life Sciences Partners (Inst); Roche Pharma AG (Inst); Servier (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)